{"id":"https://openalex.org/W4383058352","doi":"https://doi.org/10.1007/s00210-023-02585-4","title":"Infliximab abrogates adenine-induced chronic kidney disease via modulation of the MAPK/JNK/ASK signaling pathway in rats","display_name":"Infliximab abrogates adenine-induced chronic kidney disease via modulation of the MAPK/JNK/ASK signaling pathway in rats","publication_year":2023,"publication_date":"2023-07-04","ids":{"openalex":"https://openalex.org/W4383058352","doi":"https://doi.org/10.1007/s00210-023-02585-4","pmid":"https://pubmed.ncbi.nlm.nih.gov/37401969","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10771379"},"language":"en","primary_location":{"id":"doi:10.1007/s00210-023-02585-4","doi":"https://doi.org/10.1007/s00210-023-02585-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00210-023-02585-4","pdf_url":"https://link.springer.com/content/pdf/10.1007/s00210-023-02585-4.pdf","source":{"id":"https://openalex.org/S159534381","display_name":"Naunyn-Schmiedeberg s Archives of Pharmacology","issn_l":"0028-1298","issn":["0028-1298","0340-5249","1432-1912"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Naunyn-Schmiedeberg's Archives of Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","datacite","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s00210-023-02585-4.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054808986","display_name":"Mahitab Mohamed Nageeb","orcid":"https://orcid.org/0000-0003-3610-9377","observed_orcids":["https://orcid.org/0000-0003-3610-9377"]},"institutions":[{"id":"https://openalex.org/I192398990","display_name":"Zagazig University","ror":"https://ror.org/053g6we49","country_code":"EG","type":"education","lineage":["https://openalex.org/I192398990"]}],"countries":["EG"],"is_corresponding":true,"raw_author_name":"Mahitab M. Nageeb","raw_affiliation_strings":["Department of Pharmacology, Faculty of Medicine, Zagazig University, Zagazig, Egypt. MMAbdulWahab@medicine.zu.edu.eg","Department of Pharmacology, Faculty of Medicine, Zagazig University, Zagazig, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Faculty of Medicine, Zagazig University, Zagazig, Egypt. MMAbdulWahab@medicine.zu.edu.eg","institution_ids":["https://openalex.org/I192398990"]},{"raw_affiliation_string":"Department of Pharmacology, Faculty of Medicine, Zagazig University, Zagazig, Egypt","institution_ids":["https://openalex.org/I192398990"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109598729","display_name":"Aliaa Talaat","orcid":"https://orcid.org/0000-0002-8139-8967","observed_orcids":["https://orcid.org/0000-0002-8139-8967"]},"institutions":[{"id":"https://openalex.org/I192398990","display_name":"Zagazig University","ror":"https://ror.org/053g6we49","country_code":"EG","type":"education","lineage":["https://openalex.org/I192398990"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Aliaa Talaat","raw_affiliation_strings":["Department of Medical Biochemistry, Faculty of Medicine, Zagazig University, Zagazig, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Biochemistry, Faculty of Medicine, Zagazig University, Zagazig, Egypt","institution_ids":["https://openalex.org/I192398990"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055983001","display_name":"Samar Mohamed Reda","orcid":"https://orcid.org/0000-0003-0673-2790","observed_orcids":["https://orcid.org/0000-0003-0673-2790"]},"institutions":[{"id":"https://openalex.org/I192398990","display_name":"Zagazig University","ror":"https://ror.org/053g6we49","country_code":"EG","type":"education","lineage":["https://openalex.org/I192398990"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Samar M. Reda","raw_affiliation_strings":["Department of Histology and Cell Biology, Faculty of Medicine, Zagazig University, Zagazig, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Histology and Cell Biology, Faculty of Medicine, Zagazig University, Zagazig, Egypt","institution_ids":["https://openalex.org/I192398990"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077823918","display_name":"Ghada Elsammak","orcid":"https://orcid.org/0000-0001-5415-3879","observed_orcids":["https://orcid.org/0000-0001-5415-3879"]},"institutions":[{"id":"https://openalex.org/I192398990","display_name":"Zagazig University","ror":"https://ror.org/053g6we49","country_code":"EG","type":"education","lineage":["https://openalex.org/I192398990"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Ghada A. Elsammak","raw_affiliation_strings":["Department of Histology and Cell Biology, Faculty of Medicine, Zagazig University, Zagazig, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Histology and Cell Biology, Faculty of Medicine, Zagazig University, Zagazig, Egypt","institution_ids":["https://openalex.org/I192398990"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5054808986"],"corresponding_institution_ids":["https://openalex.org/I192398990"],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":{"value":4390,"currency":"USD","value_usd":4390},"fwci":1.6368,"has_fulltext":true,"cited_by_count":9,"citation_normalized_percentile":{"value":0.82799375,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"397","issue":"1","first_page":"207","last_page":"219"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.7422000169754028,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.7422000169754028,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10684","display_name":"Acute Kidney Injury Research","score":0.17720000445842743,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10291","display_name":"Dialysis and Renal Disease Management","score":0.020099999383091927,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/infliximab","display_name":"infliximab","score":1.0},{"id":"https://openalex.org/keywords/chronic-kidney-disease","display_name":"chronic kidney disease","score":0.9470000267028809},{"id":"https://openalex.org/keywords/adenine-induced-nephropathy","display_name":"adenine-induced nephropathy","score":0.9120000004768372},{"id":"https://openalex.org/keywords/anti-tnf-therapy","display_name":"anti-TNF therapy","score":0.9049999713897705},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.9359999895095825},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.6669999957084656},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.9769999980926514},{"id":"https://openalex.org/keywords/caspase-3","display_name":"caspase-3","score":0.8619999885559082},{"id":"https://openalex.org/keywords/nf-kappab","display_name":"NF-\u03baB","score":0.8840000033378601},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.9120000004768372},{"id":"https://openalex.org/keywords/nitric-oxide-synthase","display_name":"nitric oxide synthase","score":0.5899999737739563},{"id":"https://openalex.org/keywords/malondialdehyde","display_name":"malondialdehyde","score":0.6940000057220459},{"id":"https://openalex.org/keywords/neutrophil-gelatinase-associated-lipocalin","display_name":"neutrophil gelatinase-associated lipocalin","score":0.8600000143051147}],"concepts":[{"id":"https://openalex.org/C2777138892","wikidata":"https://www.wikidata.org/wiki/Q415264","display_name":"Infliximab","level":3,"score":0.8956279754638672},{"id":"https://openalex.org/C2780306776","wikidata":"https://www.wikidata.org/wiki/Q426660","display_name":"Creatinine","level":2,"score":0.6458460092544556},{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.6029577851295471},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.572770357131958},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5171591639518738},{"id":"https://openalex.org/C503630168","wikidata":"https://www.wikidata.org/wiki/Q178069","display_name":"Necrosis","level":2,"score":0.4954129457473755},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.4871899485588074},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4673220217227936},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.45746809244155884},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.45604708790779114},{"id":"https://openalex.org/C2776151105","wikidata":"https://www.wikidata.org/wiki/Q898814","display_name":"Oxidative stress","level":2,"score":0.4394804537296295},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.3846419155597687},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.23803162574768066},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.13638392090797424}],"mesh":[{"descriptor_ui":"D000069285","descriptor_name":"Infliximab","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000069285","descriptor_name":"Infliximab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000079424","descriptor_name":"Tumor Necrosis Factor Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018384","descriptor_name":"Oxidative Stress","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020935","descriptor_name":"MAP Kinase Signaling System","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051436","descriptor_name":"Renal Insufficiency, Chronic","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D051436","descriptor_name":"Renal Insufficiency, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1007/s00210-023-02585-4","doi":"https://doi.org/10.1007/s00210-023-02585-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00210-023-02585-4","pdf_url":"https://link.springer.com/content/pdf/10.1007/s00210-023-02585-4.pdf","source":{"id":"https://openalex.org/S159534381","display_name":"Naunyn-Schmiedeberg s Archives of Pharmacology","issn_l":"0028-1298","issn":["0028-1298","0340-5249","1432-1912"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Naunyn-Schmiedeberg's Archives of Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10771379","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10771379","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10771379/pdf/210_2023_Article_2585.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Naunyn Schmiedebergs Arch Pharmacol","raw_type":"Text"},{"id":"pmid:37401969","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37401969","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Naunyn-Schmiedeberg's archives of pharmacology","raw_type":"Journal Article"},{"id":"doi:10.60692/c3bdb-rer72","doi":"https://doi.org/10.60692/c3bdb-rer72","is_oa":true,"landing_page_url":"https://doi.org/10.60692/c3bdb-rer72","pdf_url":null,"source":{"id":"https://openalex.org/S7407051682","display_name":"Greater South Information System","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"},{"id":"doi:10.60692/n2h4c-mdx91","doi":"https://doi.org/10.60692/n2h4c-mdx91","is_oa":true,"landing_page_url":"https://doi.org/10.60692/n2h4c-mdx91","pdf_url":null,"source":{"id":"https://openalex.org/S7407051682","display_name":"Greater South Information System","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"}],"best_oa_location":{"id":"doi:10.1007/s00210-023-02585-4","doi":"https://doi.org/10.1007/s00210-023-02585-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00210-023-02585-4","pdf_url":"https://link.springer.com/content/pdf/10.1007/s00210-023-02585-4.pdf","source":{"id":"https://openalex.org/S159534381","display_name":"Naunyn-Schmiedeberg s Archives of Pharmacology","issn_l":"0028-1298","issn":["0028-1298","0340-5249","1432-1912"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Naunyn-Schmiedeberg's Archives of Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320321655","display_name":"Science and Technology Development Fund","ror":"https://ror.org/044vr6g03"},{"id":"https://openalex.org/F4320324156","display_name":"Zagazig University","ror":"https://ror.org/053g6we49"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4383058352.pdf","grobid_xml":"https://content.openalex.org/works/W4383058352.grobid-xml"},"referenced_works_count":42,"referenced_works":["https://openalex.org/W19843932","https://openalex.org/W78470307","https://openalex.org/W1569934359","https://openalex.org/W1985024373","https://openalex.org/W1985182233","https://openalex.org/W1989226465","https://openalex.org/W1994524645","https://openalex.org/W2002302995","https://openalex.org/W2031584115","https://openalex.org/W2031948766","https://openalex.org/W2034510342","https://openalex.org/W2034569949","https://openalex.org/W2035778488","https://openalex.org/W2047591718","https://openalex.org/W2051142023","https://openalex.org/W2056995253","https://openalex.org/W2064122617","https://openalex.org/W2074256942","https://openalex.org/W2083595902","https://openalex.org/W2086643536","https://openalex.org/W2102095386","https://openalex.org/W2107277218","https://openalex.org/W2114360920","https://openalex.org/W2118090983","https://openalex.org/W2120849943","https://openalex.org/W2548359101","https://openalex.org/W2582084066","https://openalex.org/W2595886816","https://openalex.org/W2608146344","https://openalex.org/W2764145761","https://openalex.org/W2803663965","https://openalex.org/W2889910216","https://openalex.org/W2942538509","https://openalex.org/W2947195808","https://openalex.org/W2973088173","https://openalex.org/W3125702820","https://openalex.org/W3188877759","https://openalex.org/W3203673142","https://openalex.org/W3210487338","https://openalex.org/W4211127568","https://openalex.org/W4221130309","https://openalex.org/W4225295776"],"related_works":["https://openalex.org/W2013259362","https://openalex.org/W4386580004","https://openalex.org/W4366085028","https://openalex.org/W7167904461","https://openalex.org/W3125702820","https://openalex.org/W4307425307","https://openalex.org/W7098072935","https://openalex.org/W4365443546","https://openalex.org/W4280512519","https://openalex.org/W2211008356"],"abstract_inverted_index":{"Chronic":[0],"kidney":[1,198],"disease":[2],"(CKD)":[3],"is":[4,12],"a":[5,131,148,161],"prominent":[6],"cause":[7],"of":[8,14,22,31,51,56,66,80,99,120,134,154,180],"death":[9],"worldwide.":[10],"Infliximab":[11,145],"one":[13],"the":[15,20,29,142,151,178,181,194],"anti-TNF-\u03b1;":[16],"herein,":[17],"we":[18],"studied":[19],"effect":[21,216],"infliximab":[23,72,110,135,189,210],"on":[24,37,217],"adenine-induced":[25],"CKD.":[26],"To":[27],"inspect":[28],"role":[30],"infliximab,":[32],"either":[33],"ameliorative":[34,103,213],"or":[35],"curative,":[36],"CDK":[38],"induced":[39,219],"with":[40,71,160,177,220],"adenine.":[41,221],"Thirty":[42],"Wistar":[43],"albino":[44],"rats":[45,55,65,79,98,119],"were":[46,59,69,174],"separated":[47],"into":[48],"five":[49],"groups":[50],"6":[52],"rats'":[53],"each:":[54],"group":[57,67,81,100,121],"\u0399":[58],"kept":[60],"as":[61,170],"control":[62],"given":[63,140],"saline,":[64],"II":[68],"treated":[70],"(5":[73,111,136],"mg/kg,":[74,112,137],"i.p.)":[75,113,138],"for":[76,95,114],"5":[77,96,115],"weeks,":[78,97],"\u0399\u0399\u0399":[82],"(the":[83,102,123],"diseased":[84],"group)":[85,104,125],"had":[86,105,126],"an":[87,106,212],"adenine":[88,127],"containing":[89,128],"diet":[90,108,129],"(0.25%":[91],"W/W":[92],"in":[93,141,150,164,193,203],"feed)":[94],"\u0399V":[101],"adenine-containing":[107],"and":[109,118,158,172,196,208,214],"weeks":[116],"simultaneously,":[117],"V":[122],"curative":[124,215],"then":[130],"single":[132],"dose":[133],"was":[139,186],"6th":[143],"week.":[144],"treatment":[146,190],"revealed":[147],"decrease":[149],"plasma":[152],"levels":[153],"urea,":[155],"creatinine,":[156],"NGAL,":[157],"MDA":[159],"substantial":[162],"increase":[163],"TAC.":[165],"Also,":[166,188],"inflammatory":[167],"mediators":[168],"such":[169],"IL-6":[171],"NF-\u03baB":[173],"significantly":[175],"decreased":[176],"down-regulation":[179],"ASK1/MAPK/JNK":[182],"pathway.":[183],"Caspase":[184],"3":[185],"downregulated.":[187],"exhibited":[191],"improvement":[192],"histological":[195],"immunohistochemical":[197],"changes.":[199],"Through":[200],"its":[201],"involvement":[202],"reducing":[204],"oxidative":[205],"stress,":[206],"inflammation,":[207],"apoptosis,":[209],"has":[211],"CKD":[218]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2023-07-05T00:00:00"}